Vicarious Surgical (RBOT) Cash from Financing Activities (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Cash from Financing Activities came in at $26000.0 in Q3 2025, up 8.33% on a QoQ basis from $24000.0 in Q2 2025.
Vicarious Surgical (RBOT) Cash from Financing Activities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Cash from Financing Activities data on file, last reported at $26000.0 in Q3 2025.
- On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $26000.0 in Q3 2025; TTM through Sep 2025 was $73000.0, a 102.78% increase from a year earlier, with the FY2024 full-year figure at $8000.0, down 99.98% from the prior year.
- Cash from Financing Activities for Q3 2025 stood at $26000.0, up from $24000.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for RBOT reached as high as $191.1 million in Q3 2021 and fell as low as -$486000.0 in Q4 2021.
- Historically, Cash from Financing Activities has averaged $14.5 million across 5 years, with a median of $59000.0 in 2022.
- Across the five-year window, Cash from Financing Activities tumbled 100.14% in 2021 and surged 44133.0% in 2023, its largest moves.
- Year by year, Cash from Financing Activities stood at -$486000.0 in 2021, then soared by 1913.17% to $8.8 million in 2022, then sank by 99.61% to $34000.0 in 2023, then sank by 82.35% to $6000.0 in 2024, then soared by 333.33% to $26000.0 in 2025.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were $26000.0 in Q3 2025, $24000.0 in Q2 2025, and $17000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 26,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 44.23 Mn |
| Sep 30, 2023 | 44.23 Mn |
| Jun 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 162,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 8.81 Mn |
| Dec 31, 2022 | 8.81 Mn |